Your search returned 3 results.

Results
	1.	Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspective. [electronic resource] by Pan, Feng Peng, Siyang Fleurence, Rachael Linnehan, John E Knopf, Kevin Kim, Edward Producer: 20110624 In: Clinical therapeutics vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Budgetary impact on a U.S. health plan adopting abiraterone acetate plus prednisone for the treatment of patients with metastatic castration-resistant prostate cancer. [electronic resource] by Sorensen, Sonja Ellis, Lorie Wu, Ying Hutchins, Valerie Linnehan, John E Senbetta, Mekré Producer: 20140609 In: Journal of managed care pharmacy : JMCP vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Clinical, safety, and economic evidence in radioactive iodine-refractory differentiated thyroid cancer: a systematic literature review. [electronic resource] by Anderson, Roger T Linnehan, John E Tongbram, Vanita Keating, Karen Wirth, Lori J Producer: 20130919 In: Thyroid : official journal of the American Thyroid Association vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search